Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The combined company will have greater global reach
And company has high hopes for its unlaunched BP drug, Tekturna
Ranbaxy's atorvastatin blocked after just 11 days on sale
Policy of focusing on high unmet medical need pays off
But unlikley that drug will be filed in Europe before 2009
Office of Fair Trading supports system based on patient benefit proposed
Select committee invites stakeholders to make written submissions
But company remains optimistic despite difficult times ahead
But cost and lack of comparative data could be stumbling blocks
ThromboGenics and BioInvent collaborate on developemt of TB-402 after EU grant
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches